Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Stock analysts at Atb Cap Markets issued their Q3 2025 EPS estimates for Curaleaf in a research note issued on Tuesday, March 4th. Atb Cap Markets analyst F. Gomes forecasts that the company will earn ($0.05) per share for the quarter. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Atb Cap Markets also issued estimates for Curaleaf’s Q4 2025 earnings at ($0.05) EPS.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09. The firm had revenue of $331.05 million during the quarter, compared to analysts’ expectations of $331.87 million. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%.
Get Our Latest Stock Report on Curaleaf
Curaleaf Stock Performance
OTCMKTS:CURLF opened at $1.04 on Thursday. Curaleaf has a 52 week low of $0.88 and a 52 week high of $6.40. The company has a fifty day simple moving average of $1.43 and a two-hundred day simple moving average of $2.17. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. The company has a market cap of $687.05 million, a price-to-earnings ratio of -3.59 and a beta of 0.57.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
- Five stocks we like better than Curaleaf
- Why Are These Companies Considered Blue Chips?
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Consumer Discretionary Stocks Explained
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.